Polaryx Therapeutics, Inc. PLYX 深 沪
已收盘 08-21 16:00:00 美东时间
2.07
-0.070
-3.27%
华盛通- 最 高2.15
- 今 开2.14
- 成交量 10.85万股
- 最 低 2.03
- 昨 收 2.14
- 总市值 1.03亿
- 52周最高 48.91
- 市盈率 静 --
- 换手率 0.22%
- 52周最低 1.86
- 委 比 -89.47%
- 总股本 4984.60万
- 历史最高 48.91
- 量 比 0.79
- 振 幅 5.61%
- 历史最低 1.86
- 每 手 1
- 风险率 5.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅544.53%！Scynexis获古根海姆升目标价至33美元，维持"买入"评级
今日重点评级关注：古根海姆：维持Scynexis"买入"评级，目标价从24美元升至33美元；韦德布什：维持Kura Oncology"跑赢大市"评级，目标价从36美元升至38美元
08-14 11:51
Raymond James Initiates Coverage On Polaryx Therapeutics with Strong Buy Rating, Announces Price Target of $6
Raymond James analyst Tiago Fauth initiates coverage on Polaryx Therapeutics (NASDAQ:PLYX) with a Strong Buy rating and announces Price Target of $6.
08-13 18:32
美股大行评级 | ITG、Bending Spoons获多家大行首予买入评级；瑞银下调微软目标价从510美元降至480美元
今日重点评级关注：BTIG：上调Outlook Therapeutics"买入"评级，目标价4美元；TD Cowen：维持Nakamoto"买入"评级，目标价从1美元升至17美元
07-28 11:34
LUCID CAPITAL MARKETS Initiates Coverage On Polaryx Therapeutics with Buy Rating, Announces Price Target of $7
LUCID CAPITAL MARKETS analyst Dev Prasad initiates coverage on Polaryx Therapeutics (NASDAQ:PLYX) with a Buy rating and announces Price Target of $7.
07-27 20:04
美股大行评级 | 潜在涨幅246.92%！HC Wainwright & Co.上调Rockwell Medical(RMTI)目标价至20美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Rockwell Medical"买入"评级，目标价从2美元升至20美元；Canaccord Genuity：维持创力"买入"评级，目标价从10.5美元升至11美元
07-10 17:36
HC Wainwright & Co. Initiates Coverage On Polaryx Therapeutics with Buy Rating, Announces Price Target of $7
HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Polaryx Therapeutics (NASDAQ:PLYX) with a Buy rating and announces Price Target of $7.
07-09 18:09
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers INVO Fertility (NASDAQ:IVF) shares increased by 33.0% to $2.5 during F...
05-30 05:05
Polaryx Therapeutics shares are trading higher after the company announced closing of a $10 million private investment in public equity financing.
Polaryx Therapeutics shares are trading higher after the company announced clos...
05-28 23:24
Why Polaryx Therapeutics Stock Is Surging On Thursday?
Polaryx Therapeutics (NASDAQ: PLYX) stock climbs on Thursday following a $10M private placement to launch its Phase 2 SOTERIA trial for rare lysosomal storage disorders.
05-28 22:45
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers BioLine Rx (NASDAQ:BLRX) stock increased by 12.5% to $3.11 during Mond...
05-19 05:05
